ASEP Medical Holdings Inc. announced a a non-brokered private placement of up to 10,000,000 units at a price of CAD 0.20 per unit for aggregate gross proceeds of up to CAD 2,000,000 on November 30, 2023. Each unit will consist of one common share in the capital of the company and one non-transferable common share purchase warrant. Each warrant will be exercisable into one common share at a price of CAD 0.26 per warrant share for a period of 2 years. The units offered will not be subject to resale restrictions for Canadian resident investors pursuant to applicable Canadian securities laws. The offering is anticipated to close in one or more tranches with the final tranche of the offering closing within 45 days from the date hereof. The closing is subject to certain conditions including, but not limited to, the receipt of all necessary regulatory and other approvals, including the company?s completion of its filing obligations under the policies of the Canadian Securities Exchange. The company may pay finder?s fees under the offering as permitted by CSE policy and applicable securities laws. The company will pay to each finder on the date of closing of the offering, a cash commission of 8% of the gross proceeds raised in respect of the offering from subscribers introduced by the finder. In addition, upon the closing of the offering, the company shall issue to each finder, common share purchase warrants, exercisable for a period of two years following the closing date, to acquire in aggregate that number of common shares which is equal to 8% of the number of Units sold under the offering to subscribers introduced by the finder at an exercise price equal to CAD 0.26 per finder?s warrant share. Any securities issued as
finder?s fees will be subject to a 4 month hold period.